Cargando…

Inflammatory microenvironment of fibrotic liver promotes hepatocellular carcinoma growth, metastasis and sorafenib resistance through STAT3 activation

The pro‐inflammatory and pro‐fibrotic liver microenvironment facilitates hepatocarcinogenesis. However, the effects and mechanisms by which the hepatic fibroinflammatory microenvironment modulates intrahepatic hepatocellular carcinoma (HCC) progression and its response to systematic therapy remain l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Yuchuan, Chen, Peng, Hu, Kaishun, Dai, Guanqi, Li, Jinying, Zheng, Dandan, Yuan, Hui, He, Lu, Xie, Penghui, Tu, Mengxian, Peng, Shuang, Qu, Chen, Lin, Wenyu, Chung, Raymond T., Hong, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7875922/ https://www.ncbi.nlm.nih.gov/pubmed/33410581 http://dx.doi.org/10.1111/jcmm.16256

Ejemplares similares

Dexmedetomidine promotes the progression of hepatocellular carcinoma through hepatic stellate cell activation
por: Chen, Peng, et al.
Publicado: (2020)

The fibrotic and immune microenvironments as targetable drivers of metastasis
por: Boulter, Luke, et al.
Publicado: (2020)

EFTUD2 maintains the survival of tumor cells and promotes hepatocellular carcinoma progression via the activation of STAT3
por: Tu, Mengxian, et al.
Publicado: (2020)

Gankyrin induces STAT3 activation in tumor microenvironment and sorafenib resistance in hepatocellular carcinoma
por: Sakurai, Toshiharu, et al.
Publicado: (2017)

Sorafenib Attenuates Fibrotic Hepatic Injury Through Mediating Lysine Crotonylation
por: Chen, Xiao-Feng, et al.
Publicado: (2022)

The fibrotic microenvironment as a heterogeneity facet of hepatocellular carcinoma
por: Rombouts, Krista, et al.
Publicado: (2013)

Remodeling the hepatic fibrotic microenvironment with emerging nanotherapeutics: a comprehensive review
por: Zhao, Xingtao, et al.
Publicado: (2023)

Correction: Remodeling the hepatic fibrotic microenvironment with emerging nanotherapeutics: a comprehensive review
por: Zhao, Xingtao, et al.
Publicado: (2023)

The current status of tumor microenvironment and cancer stem cells in sorafenib resistance of hepatocellular carcinoma
por: Chen, Siqi, et al.
Publicado: (2023)

NUSAP1, a novel stemness‐related protein, promotes early recurrence of hepatocellular carcinoma
por: Li, Jinying, et al.
Publicado: (2022)

Link of sorafenib resistance with the tumor microenvironment in hepatocellular carcinoma: Mechanistic insights
por: Tian, Xinchen, et al.
Publicado: (2022)

Defining the Cardiac Fibroblast Secretome in a Fibrotic Microenvironment
por: Ceccato, Tova L., et al.
Publicado: (2020)

Intrahepatic cholangiocarcinoma induced M2-polarized tumor-associated macrophages facilitate tumor growth and invasiveness
por: Yuan, Hui, et al.
Publicado: (2020)

The Role of JAK/STAT Pathway in Fibrotic Diseases: Molecular and Cellular Mechanisms
por: Liu, Jia, et al.
Publicado: (2023)

Chemical and genetic inhibition of STAT3 sensitizes hepatocellular carcinoma cells to sorafenib induced cell death
por: Xie, Linna, et al.
Publicado: (2018)

miR-21 enhances cardiac fibrotic remodeling and fibroblast proliferation via CADM1/STAT3 pathway
por: Cao, Wei, et al.
Publicado: (2017)

Sorafenib inhibits caspase-1 expression through suppressing TLR4/stat3/SUMO1 pathway in hepatocellular carcinoma
por: Li, Jun, et al.
Publicado: (2018)

Pancreatic carcinoma metastasis to a lung carcinoma lesion and pulmonary fibrotic regions, overtaking the stromal microenvironment: A case report
por: Nakaya, Takeo, et al.
Publicado: (2019)

Hepatocellular Carcinoma with Distant Metastasis Cured by 20-Day Sorafenib Treatment
por: Kim, Seok Bae
Publicado: (2021)

Sorafenib for the treatment of solid malignancies: what about the cancer microenvironment?
por: Tomuleasa, Ciprian, et al.
Publicado: (2013)

Therapeutic Strategies to Overcome Fibrotic Barriers to Nanomedicine in the Pancreatic Tumor Microenvironment
por: Tanaka, Hiroyoshi Y., et al.
Publicado: (2023)

MYC-targeted WDR4 promotes proliferation, metastasis, and sorafenib resistance by inducing CCNB1 translation in hepatocellular carcinoma
por: Xia, Peng, et al.
Publicado: (2021)

Mitochondrial Plasticity Promotes Resistance to Sorafenib and Vulnerability to STAT3 Inhibition in Human Hepatocellular Carcinoma
por: Pandit, Shusil K., et al.
Publicado: (2021)

Contribution of STAT3 to Inflammatory and Fibrotic Diseases and Prospects for its Targeting for Treatment
por: Kasembeli, Moses M., et al.
Publicado: (2018)

Camrelizumab Plus Sorafenib Versus Sorafenib Monotherapy for Advanced Hepatocellular Carcinoma: A Retrospective Analysis
por: Liu, Qinqin, et al.
Publicado: (2021)

IL-6/STAT3 Signaling Contributes to Sorafenib Resistance in Hepatocellular Carcinoma Through Targeting Cancer Stem Cells
por: Li, Yu, et al.
Publicado: (2020)

SC-2001 Overcomes STAT3-mediated Sorafenib Resistance through RFX-1/SHP-1 Activation in Hepatocellular Carcinoma()()
por: Su, Jung-Chen, et al.
Publicado: (2014)

Metformin promotes ferroptosis and sensitivity to sorafenib in hepatocellular carcinoma cells via ATF4/STAT3
por: Hu, Zongqiang, et al.
Publicado: (2023)

Fibrotic liver microenvironment promotes Dll4 and SDF-1-dependent T-cell lineage development
por: Gong, Zheng, et al.
Publicado: (2019)

Sorafenib Alleviates Inflammatory Signaling of Tumor Microenvironment in Precancerous Lung Injuries
por: Cicek, Betul, et al.
Publicado: (2023)

Radiation-Induced Fibrotic Tumor Microenvironment Regulates Anti-Tumor Immune Response
por: Nam, Jae-Kyung, et al.
Publicado: (2021)

Human Neutrophil α-Defensins 1–3 Are Upregulated in the Microenvironment of Fibrotic Liver
por: Abu Fanne, Rami, et al.
Publicado: (2023)

LncRNA DANCR Promotes Sorafenib Resistance via Activation of IL-6/STAT3 Signaling in Hepatocellular Carcinoma Cells
por: Liu, Yuan, et al.
Publicado: (2020)

Distinct Behaviour of Sorafenib in Experimental Cachexia-Inducing Tumours: The Role of STAT3
por: Toledo, Míriam, et al.
Publicado: (2014)

Nalidixic acid potentiates the antitumor activity in sorafenib-resistant hepatocellular carcinoma via the tumor immune microenvironment analysis
por: Liu, Zhi-Yong, et al.
Publicado: (2022)

Pyroptosis-Related lncRNAs for Predicting the Prognosis and Identifying Immune Microenvironment Infiltration in Breast Cancer Lung Metastasis
por: Liu, Li, et al.
Publicado: (2022)

The Combination of R848 with Sorafenib Enhances Antitumor Effects by Reprogramming the Tumor Immune Microenvironment and Facilitating Vascular Normalization in Hepatocellular Carcinoma
por: He, Yuchao, et al.
Publicado: (2023)

Cyclin Y Modulates the Proliferation, Invasion, and Metastasis of Hepatocellular Carcinoma Cells
por: Shi, Kaishun, et al.
Publicado: (2018)

Identification of Pparγ-modulated miRNA hubs that target the fibrotic tumor microenvironment
por: Winkler, Ivana, et al.
Publicado: (2020)

18. Tissue Microenvironment Affects Fibrotic Capsules Formed during Foreign Body Response
por: Parker, Jennifer Brigitta Laufey, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_k7kib48cls10m3vamarpgjbtaf